Bar will share insight on foldover interpolated flaps for full thickness of nasal defects.
Two new forms of Trichophyton mentagrophytes type VII and Trichophyton indotineae are emerging, according to a new report.
Brauer’s textbook can be purchased through Amazon and Barnes & Noble.
Data presented at the American Academy of Dermatology 2022 Annual Meeting shows what supplements can and cannot manage alopecia areata.
Alan Irvine, MD, DSc, shares insights on the impact of ruxolitinib on quality of life in pediatric patients and 2024 AAD research presentations to take into consideration.
Sachin Shridharani, MD, FACS, discusses the READY-1 and READY-2 clinical trials and positive support for Relfydess.
Marc Hurlbert, PhD, discusses how the Melanoma Research Alliance works with dermatology clinicians to provide fundings and resources for melanoma research.
An expert in dermatology shares his insights into the management considerations with traditionally utilized treatments for generalized pustular psoriasis and discusses the impact of a recent approval in this space.
Defining the goals of the mentoring relationship can be useful to clarify expectations.
Katie Schlenker, DO, emphasizes the importance of empathy during tough conversations with skin cancer patients with few to no treatment options left.
The topical cream is the first acne drug with a new mechanism of action to win FDA approval in the last 40 years.
Blackburn presented integrative medicine pearls on gut and hormone health at the 2024 Diversity in Dermatology meeting.
At the 2024 SDPA Fall Conference, Sara Wilchowski, DMSc, MPAS, PA-C, highlighted the challenges and rewards of transitioning to industry roles, the impact of “Insta-Tok” on patient care, and the evolving landscape of dermatology.
We had the chance to catch up with Serrao before he took the stage and he explained why dermatology clinicians should keep their eyes on bimekizumab’s data and shared opportunities for further research.
A coprimary end point in the phase 3 LEAP-010 study will not be met.
Explore how cultural competency in aesthetic dermatology bridges trust gaps, ensuring inclusive care for patients of color and enhancing treatment outcomes.
New research reveals a promising strategy to slow type 1 diabetes progression by targeting inflammation with an existing psoriasis drug.
The ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.
Mitragotri's work bridges advanced drug development and skin care for tailored treatments.
At the 2025 Revolutionizing Atopic Dermatitis Conference, JiaDe “Jeff” Yu, MD, MS, discussed the multifactorial nature of chronic hand eczema, highlighting its distinction from atopic dermatitis.
Christopher Bunick, MD, PhD, highlights how dupilumab transforms atopic dermatitis treatment in children, improving health outcomes and quality of life beyond skin symptoms.
Aesthetic medicine embraces a holistic approach to skin quality, defining it through measurable categories that enhance personalized treatment strategies.
According to new research from Steven Dayan, MD, FACS, PROs are reshaping aesthetic medicine, enhancing Botox treatment insights and prioritizing holistic patient care.